UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 135

Sortiert nach

Pharmacogenetic markers of toxicity for chemotherapy in colorectal cancer patients

Pharmacogenomics, 2012-07, Vol.13 (10), p.1173-1191

2012

Volltextzugriff (PDF)

Identification of new SNPs associated with severe toxicity to capecitabine

Pharmacological research, 2017-06, Vol.120, p.133-137

2017

Volltextzugriff (PDF)

Genomic Profiling of Circulating Plasma RNA for the Analysis of Cancer

Clinical chemistry (Baltimore, Md.), 2007-10, Vol.53 (10), p.1860-1863

2007

Volltextzugriff (PDF)

Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children

Pharmacological research, 2023-08, Vol.194, p.106859-106859, Article 106859

2023

Volltextzugriff (PDF)

Comments on: Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children

Pharmacological research, 2023-10, Vol.196, p.106938-106938, Article 106938

2023

Volltextzugriff (PDF)

Using pharmacogenetics to prevent severe adverse reactions to capecitabine

Pharmacogenomics, 2017-08, Vol.18 (13), p.1199-1213

2017

Volltextzugriff (PDF)

Genetic Predictors of Long‐term Response to Antitumor Necrosis Factor Agents in Pediatric Inflammatory Bowel Disease

Journal of pediatric gastroenterology and nutrition, 2020-10, Vol.71 (4), p.508-515

2020

Volltextzugriff (PDF)

Clinical utility of ABCB1 genotyping for preventing toxicity in treatment with irinotecan

Pharmacological research, 2018-10, Vol.136, p.133-139

2018

Volltextzugriff (PDF)

The cytosolic aldehyde dehydrogenase gene ( Aldh1) is developmentally expressed in Leydig cells

FEBS letters, 1997-04, Vol.407 (2), p.225-229

1997

Volltextzugriff (PDF)

Regulatory CDH4 Genetic Variants Associate With Risk to Develop Capecitabine‐Induced Hand‐Foot Syndrome

Clinical pharmacology and therapeutics, 2021-02, Vol.109 (2), p.462-470

2021

Volltextzugriff (PDF)

Carbosilane Dendrimers to Transfect Human Astrocytes with Small Interfering RNA Targeting Human Immunodeficiency Virus

BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy, 2010-10, Vol.24 (5), p.331-343

2010

Volltextzugriff (PDF)

Comparison of a new rapid method for determination of serum anti-adalimumab and anti-infliximab antibodies with two established ELISA kits

Journal of pharmaceutical and biomedical analysis, 2021-05, Vol.198, p.114003-114003, Article 114003

2021

Volltextzugriff (PDF)

Evaluating the role of ENOSF1 and TYMS variants as predictors in fluoropyrimidine-related toxicities: An IPD meta-analysis

Pharmacological research, 2020-02, Vol.152, p.104594, Article 104594

2020

Volltextzugriff (PDF)

Comparison of a new rapid method for the determination of adalimumab serum levels with two established ELISA kits

Clinical chemistry and laboratory medicine, 2019-11, Vol.57 (12), p.1906

2019

Volltextzugriff (PDF)

Genetic predictors of long-term response and trough levels of infliximab in crohn’s disease

Pharmacological research, 2019-11, Vol.149, p.104478-104478, Article 104478

2019

Volltextzugriff (PDF)

Cost-effectiveness of screening for DPYD polymorphisms to prevent neutropenia in cancer patients treated with fluoropyrimidines

Pharmacogenomics, 2016-06, Vol.17 (9), p.979-984

2016

Volltextzugriff (PDF)

The Effect of Polymorphisms and Other Biomarkers on Infliximab Exposure in Paediatric Inflammatory Bowel Disease: Development of a Population Pharmacokinetic Model

Paediatric drugs, 2024-05, Vol.26 (3), p.331-346

2024

Volltextzugriff (PDF)

Gene-expression profiling in pancreatic cancer

Expert review of molecular diagnostics, 2010-07, Vol.10 (5), p.591-601

2010

Volltextzugriff (PDF)

Comments on: “Clinical utility of ABCB1 genotyping for preventing toxicity in treatment with irinotecan”

Pharmacological research, 2019-07, Vol.145, p.104288-104288, Article 104288

2019

Volltextzugriff (PDF)

Use of exome sequencing to determine the full profile of genetic variants in the fluoropyrimidine pathway in colorectal cancer patients affected by severe toxicity

Pharmacogenomics, 2017-08, Vol.18 (13), p.1215-1223

2017

Volltextzugriff (PDF)

Ammonia induces aquaporin-4 rearrangement in the plasma membrane of cultured astrocytes

Neurochemistry international, 2012-12, Vol.61 (8), p.1314-1324

2012

Volltextzugriff (PDF)

Identification of genetic variants associated with capecitabine-induced hand–foot syndrome through integration of patient and cell line genomic analyses

Pharmacogenetics and genomics, 2014-05, Vol.24 (5), p.231-237

2014

Volltextzugriff (PDF)

Interferon-stimulated genes are associated with peginterferon/ribavirin treatment response regardless of IL28B alleles in hepatitis C virus/HIV-coinfected patients

AIDS (London), 2013-03, Vol.27 (5), p.687-696

2013

Volltextzugriff (PDF)

Changes in Gene Expression Pattern of Human Primary Macrophages Induced by Carbosilane Dendrimer 2G-NN16

Pharmaceutical research, 2009-03, Vol.26 (3), p.577-586

2009

Volltextzugriff (PDF)

ABCB1 gene polymorphisms are associated with adverse reactions in fluoropyrimidine-treated colorectal cancer patients

Pharmacogenomics, 2010-12, Vol.11 (12), p.1715-1723

2010

Volltextzugriff (PDF)

1 – 25 von 135

Suche als RSS-Feed

Aktive Filter

KollektionWK Lippincott Williams & Wilkins–Connect here FIRST to enable access

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(132)
Mit Volltextzugriff
(120)

Publikationsform

Artikel
(133)
Berichte
(1)
Reviews
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Pharmacogenetic markers of toxicity for chemotherapy in colorectal cancer patients

Identification of new SNPs associated with severe toxicity to capecitabine

Genomic Profiling of Circulating Plasma RNA for the Analysis of Cancer

Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children

Comments on: Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children

Using pharmacogenetics to prevent severe adverse reactions to capecitabine

Genetic Predictors of Long‐term Response to Antitumor Necrosis Factor Agents in Pediatric Inflammatory Bowel Disease

Clinical utility of ABCB1 genotyping for preventing toxicity in treatment with irinotecan

The cytosolic aldehyde dehydrogenase gene ( Aldh1) is developmentally expressed in Leydig cells

Regulatory CDH4 Genetic Variants Associate With Risk to Develop Capecitabine‐Induced Hand‐Foot Syndrome

Carbosilane Dendrimers to Transfect Human Astrocytes with Small Interfering RNA Targeting Human Immunodeficiency Virus

Comparison of a new rapid method for determination of serum anti-adalimumab and anti-infliximab antibodies with two established ELISA kits

Evaluating the role of ENOSF1 and TYMS variants as predictors in fluoropyrimidine-related toxicities: An IPD meta-analysis

Comparison of a new rapid method for the determination of adalimumab serum levels with two established ELISA kits

Genetic predictors of long-term response and trough levels of infliximab in crohn’s disease

Cost-effectiveness of screening for DPYD polymorphisms to prevent neutropenia in cancer patients treated with fluoropyrimidines

The Effect of Polymorphisms and Other Biomarkers on Infliximab Exposure in Paediatric Inflammatory Bowel Disease: Development of a Population Pharmacokinetic Model

Gene-expression profiling in pancreatic cancer

Comments on: “Clinical utility of ABCB1 genotyping for preventing toxicity in treatment with irinotecan”

Use of exome sequencing to determine the full profile of genetic variants in the fluoropyrimidine pathway in colorectal cancer patients affected by severe toxicity

Ammonia induces aquaporin-4 rearrangement in the plasma membrane of cultured astrocytes

Identification of genetic variants associated with capecitabine-induced hand–foot syndrome through integration of patient and cell line genomic analyses

Interferon-stimulated genes are associated with peginterferon/ribavirin treatment response regardless of IL28B alleles in hepatitis C virus/HIV-coinfected patients

Changes in Gene Expression Pattern of Human Primary Macrophages Induced by Carbosilane Dendrimer 2G-NN16

ABCB1 gene polymorphisms are associated with adverse reactions in fluoropyrimidine-treated colorectal cancer patients

Aktive Filter

Suchergebnisse filtern